{
    "clinical_study": {
        "@rank": "23468", 
        "acronym": "SPN2", 
        "arm_group": [
            {
                "arm_group_label": "Enteral nutrition only", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Enteral nutrition to be progressed as soon as possible to energy target measured on day 3, and verified on day 4, using the usual facilitators (prokinetics)"
            }, 
            {
                "arm_group_label": "Supplemental parenteral nutrition", 
                "arm_group_type": "Experimental", 
                "description": "Addition of supplemental parenteral nutrition to complete the gap between energy delivered by enteral feeding and energy target measured on day 4.\nAim: 100% of this target, and not exceeding it, no catch up for energy deficit accumulated before day 4."
            }
        ], 
        "brief_summary": {
            "textblock": "Having previously demonstrated that supplemental parenteral nutrition to complete an\n      insufficient enteral nutrition (EN) between D4 and D8 improves outcome after critical\n      illness, by reducing infectious complications, the present trial aims at investigating the\n      underlying carbohydrate and protein metabolism changes, as well as the immune and\n      inflammatory modulations associated with this improvement."
        }, 
        "brief_title": "Impact of Supplemental Parenteral Nutrition in ICU Patients on Metabolic, Inflammatory and Immune Responses", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Critical Illness", 
        "condition_browse": {
            "mesh_term": "Critical Illness"
        }, 
        "detailed_description": {
            "textblock": "Enrollment on day 3 of critically ill patients, without contraindication to EN, not\n      achieving 60% of the ICU per protocol energy target.\n\n      Intervention: Randomization to either continued pure EN, or from day 4 to supplemental PN to\n      complete EN at target validated by indirect calorimetry.\n\n      Measurements: Indirect calorimetry on Days 3, 4, 9 (twice). Primary endpoints = glucose and\n      leucine metabolism On days 4 and 9-10: isotopic investigation of glucose metabolism, and\n      immune and inflammatory responses// Day 9-10: isotopic investigation of protein (leucine)\n      metabolism Secondary endpoints: Insulin requirements, area under the curve (AUC) of blood\n      Glucose, infections after day 9, overall complications, length of mechanical ventilation, of\n      ICU and hospital stay."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  estimated duration of ICU stay > 5 days,\n\n          -  estimated survival > 7 days,\n\n          -  absence of contraindication to EN\n\n          -  need for mechanical ventilation\n\n          -  informed consent obtained from patients, close relative, or referring physician\n\n        Exclusion Criteria:\n\n          -  refusal of the patient or of the next of kin\n\n          -  age < 18 years\n\n          -  non-functional digestive tract (short bowel, persistent ileus, proximal intestinal\n             fistula high rate  > 1.5 litres/day)\n\n          -  already receiving PN before Day 3\n\n          -  absence of a central venous catheter\n\n          -  women who are pregnant (pregnancy test).\n\n          -  Admission after cardiac arrest, or severe brain injury"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02022813", 
            "org_study_id": "CE 371-13"
        }, 
        "intervention": {
            "arm_group_label": "Supplemental parenteral nutrition", 
            "description": "The amount of energy delivered by SPN will depend on the indirect calorimetry measurement and actual enteral feed delivery. SPN will be reduced with progressing EN", 
            "intervention_name": "Supplemental parenteral nutrition (SPN)", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Standard industrial PN solutions"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Energy requirements, Glucose turnover, Protein turnover", 
        "lastchanged_date": "December 22, 2013", 
        "location": [
            {
                "contact": {
                    "email": "Claude.Pichard@unige.ch", 
                    "last_name": "Claude Pichard, MD PhD", 
                    "phone": "+41 22 372 93 75"
                }, 
                "facility": {
                    "address": {
                        "city": "Geneva", 
                        "country": "Switzerland", 
                        "state": "GE", 
                        "zip": "1211"
                    }, 
                    "name": "Nutrition Unit, Geneva University Hospital"
                }, 
                "investigator": {
                    "last_name": "Claude Pichard, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Mette.Berger@chuv.ch", 
                    "last_name": "Mette M Berger, MD PhD", 
                    "phone": "+41 21 31 42 095"
                }, 
                "contact_backup": {
                    "email": "Luc.Tappy@unil.ch", 
                    "last_name": "Luc Tappy, Md PhD", 
                    "phone": "+41 21 692 55 41"
                }, 
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "state": "VD", 
                        "zip": "1011"
                    }, 
                    "name": "Service of Adult Intensive Care - CHUV"
                }, 
                "investigator": [
                    {
                        "last_name": "Mette M Berger, MD PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Francois Spertini, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "zip": "1005"
                    }, 
                    "name": "Physiology Department, Unil"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Impact of Supplemental Parenteral Nutrition (SPN) on Energy Balance, and Infection Rate in Intensive Care Patients: Underlying Metabolic, Inflammatory and Immune Mechanisms.", 
        "other_outcome": {
            "description": "Overall complications and organ failures, length of mechanical ventilation, length of ICU and hospital stay.", 
            "measure": "Global outcome", 
            "safety_issue": "Yes", 
            "time_frame": "28 days / 90 days"
        }, 
        "overall_contact": {
            "email": "Mette.Berger@chuv.ch", 
            "last_name": "Mette M Berger, MD PhD", 
            "phone": "+41 21 31 42 095"
        }, 
        "overall_contact_backup": {
            "email": "Claude.Pichard@unige.ch", 
            "last_name": "Claude Pichard, MD PhD", 
            "phone": "+41 22 372 93 45"
        }, 
        "overall_official": {
            "affiliation": "CHUV, Lausanne", 
            "last_name": "Mette M Berger, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "On D04:Infusion after priming of 6.6 2H2 glucose and NaH13CO3 On Day 09-10: Infusion after priming of NaH13CO3 and of L-[1-13C]-Leucine + repeat of the glucose sequence", 
            "measure": "Glucose and Leucine turnover", 
            "safety_issue": "No", 
            "time_frame": "10 days"
        }, 
        "reference": {
            "PMID": "23218813", 
            "citation": "Heidegger CP, Berger MM, Graf S, Zingg W, Darmon P, Costanza MC, Thibault R, Pichard C. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet. 2013 Feb 2;381(9864):385-93. doi: 10.1016/S0140-6736(12)61351-8. Epub 2012 Dec 3."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02022813"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Universitaire Vaudois", 
            "investigator_full_name": "Mette M Berger", 
            "investigator_title": "Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "lymphocyte phenotypes: lymphocyte subpopulations (frequency), level of activation (CD69), memory markers, effectors, regulators\nCluster differentiation CD4, CD8, and natural killer (NK) phenotypes\nCell inflammatory response (WBA and PBMC) on D4 and D10\u00b11: IL-2, TNF-\u03b1, interleukine-6 (IL-6), IL-1, TGF, IL-10, in culture for 24 to 48h ex vivo and post stimulation by memory mix and mitogens.\nSerological inflammatory response (WBA and PBMC) on D4 and D10+1: TNF-\u03b1 , IL-6, C-reactive protein (CRP): ex vivo with ELISA Nosocomial infections after day 8", 
            "measure": "Immune and inflammatory impact of optimized target feeding", 
            "safety_issue": "No", 
            "time_frame": "10 days"
        }, 
        "source": "Centre Hospitalier Universitaire Vaudois", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Geneva, Switzerland", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Vaudois", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}